Who Paid My Doc
Columvi
Biological BioOncology
NDC 50242-125-01
General payments
$1,051,867
Research payments
$37,355,258
Through program year 2025, $1,051,867 in general payments and $37,355,258 in research payments were reported against Columvi (BioOncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $374,729 | 764 |
| 2025 | Research | $21,414,083 | 1,057 |
| 2024 | General | $346,686 | 3,363 |
| 2024 | Research | $7,575,227 | 550 |
| 2023 | General | $330,453 | 2,161 |
| 2023 | Research | $8,365,948 | 305 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 36 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 45 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
6,288 general · 1,912 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.